Insider · SEC Form 4 · EVP & CFO
Terrance P. Coyne
Filed with the SEC as Coyne Terrance P.; the order above is the one the filer's own signature uses.
In the 12 months to Nov 19, 2026, on the open market: sold $18.3M of RPRX. Filed a median of 2 business days after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
- RPRXSold: Royalty Pharma plc $1.7M
- RPRXSold: Royalty Pharma plc $16.0M
- RPRXSold: Royalty Pharma plc $646K
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
Planned sales (Form 144)
A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Notices filed under this filer's SEC CIK in the same 12 months, newest first; the figure is the market value the notice states. Not every notice becomes a sale. Every recent notice
- RPRXTerrance Coyne $17.6M
Other Form 4 entries
Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.
- RPRX: grant or award (code A), 2 entries, Aug 5 to Nov 4, 2026
- RPRX: conversion (code C), 2 entries, Nov 6, 2026
- Code A
- A grant or award from the company, such as stock given as pay.
- Code C
- A conversion of a derivative security, such as preferred stock or units, into shares.
Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.